McDermott Hires Michael Sitzman as Intellectual Property Partner

Michael Sitzman joined McDermott Will & Emery as a partner in its intellectual property practice group in San Francisco, the firm announced Tuesday.

Sitzman represents biotechnology and brand-side pharmaceutical companies in high-stakes biologic and drug patent litigation, the firm said.

He has litigated cases involving recombinant DNA, chimeric antigen receptor technology, glycobiology, small molecule drugs, antisense technology, protein synthesis and regulation, and immunological markers.

This story was produced by Bloomberg Law Automation.